Evaluation of hepatitis B and C viral markers: Clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 10, 1996, Pages 949-954

  Hwang, Shinn Jang ^a   Tong, Myron J ^a   Lai, Paul P C ^a   Ko, Edison S ^a   Co, Ruth L ^a   Chien, David ^b   Kuo, George ^b  

^a HUNTINGTON MEMORIAL HOSPITAL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

antibody to hepatitis C virus; Asian Americans; Caucasians; hepatitis B surface antigen; hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; ETHNOLOGY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; UNITED STATES;

EID: 0029845221     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00279.x     Document Type: Article

References (35)

1. Okuda K. Geographic heterogeneity of hepatocellular carcinoma. Gastroenterol. Jpn. 1990; 25: 782-92.
2. Tong MJ, Sun SC, Schaeffer BT, Chang NK, Lo KJ, Peters RL. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan. Ann. Intern. Med. 1971; 75: 687-91.
3. Kew MC, Desmyter J, Bradburne AF, Macnab GM. Hepatitis-B virus infection in southern African Blacks with hepatocellular carcinoma. J. Natl Cancer Inst. 1979; 62: 517-20.
4. Beasley RP, Hwang LY, Lin CC et al. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22 707 men in Taiwan. Lancet 1981; 2: 1129-33.
5. Okuda K. Hepatocellular carcinoma: Recent progress. Hepatology 1992; 15: 948-63.
6. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J. Natl Cancer Inst. 1990; 82: 1038-41.
7. Di Bisceglie AM, Order SE, Klein JL et al. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am. J. Gastroenterol. 1991; 86: 335-8.
8. Peters RL, Afroudakis AP, Tatter D. The changing incidence of association of hepatitis B with hepatocellular carcinoma. Am. J. Clin. Pathol. 1977; 68: 1-7.
9. Tong MJ, Weiner JM, Ashcavai MW, Vyas GN. Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer 1979; 44: 2338-42.
10. Tong MJ, Chlebowski RT, Weissman JY, Bateman JR. Frequency and treatment of primary hepatocellular carcinoma in Los Angeles. Prog. Med. Virol. 1981; 27: 6-13.
11. Bruix J, Barrera JM, Calvet X et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; ii: 1004-6.
12. Nishioka K, Watanabe J, Furuta S et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429-33.
13. Hardell L, Bengtsson NO, Jonsson U et al. Aetiological aspects of primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria: An epidemiological investigation. Br. J. Cancer 1984; 50: 389-97.
14. Scudamore CH, Ragaz J, Kluftinger AM et al. Hepatocellular carcinoma: A comparison of Oriental and Caucasian patients. Am. J. Surg. 1988; 155: 659-62.
15. Lin-Fu JS. Population characteristics and health care needs of Asian Pacific Americans. Public Health Rep. 1988; 103: 18-27.
16. Changing racial composition of metropolitan areas. Stat. Bull. 1992; 73: 2-9.
17. Szmuness W, Stevens CE, Ikram H, Much MI, Hardly FJ, Hollinger B. Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans. J. Infect. Dis. 1978; 137: 822-9.
18. Poenaru D, Szilagyi A, Zabad F, Lamoureux E, Lough JO. Hepatocellular carcinoma: Comparison of clinical features among ethnic groups in an area of low prevalence. Am. J. Gastroenterol. 1991; 86: 487-94.
19. Barker JC. Culture diversity: Changing the context of medical practice. West. J. Med. 1992; 157: 248-54.
20. Chien DY, Choo QL, Tabrizi A et al. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc. Natl Acad. Sci. USA 1992; 89: 10011-5.
21. Tong MJ, Lee SY, Hwang SJ et al. Antibodies to hepatitis C and detection of HCV RNA in patients with primary hepatocellular carcinoma. West. J. Med. 1994; 160: 133-8.
22. Catanzaro A, Moster R. Health status of refugees from Vietnam, Laos, and Cambodia. JAMA 1982; 247: 1303-8.
23. Screening for hepatitis B virus infection among refugees arriving in the United States, 1979-1991. Mortal Morbid Weekly Report 1991; 40: 784-6.
24. Tong MJ, Yu M, Co RL, Eastin B. Hepatitis B virus markers in the foreign-born Chinese population of Los Angeles, California. J. Infect. Dis. 1984; 149: 475.
25. Szmuness W, Hirsch RL, Prince AM, Levine RW, Harley EJ, Ikram H. Hepatitis B surface antigen in blood donor: further evaluations. J. Infect. Dis. 1975; 131: 111-18.
26. Chen DS, Kuo GC, Sung JL et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience. J. Infect. Dis. 1990; 162: 817-22.
27. Lee SD, Lee FY, Wu JC, Hwang SJ, Wang SS, Lo KJ. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 1992; 69: 342-5.
28. Beasley RP, Hwang LY. Post-natal infectivity of hepatitis B surface antigen carrier mothers. J. Infect. Dis. 1983; 147: 185-90.
29. Whittle HC, Bradley AK, McLaughlin K et al. Hepatitis B virus infection in two Gambian village. Lancet 1993; i: 1203-6.
30. Tong MJ, Weiner JM, Ashcavai MW, Redeker AG, Comparini S, Vyas GN. A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J. Infect. Dis. 1979; 140: 506-12.
31. Tong MG, Co RL. Hepatitis B virus markers in Asian families. Ann. Intern. Med. 1985; 103: 307-8.
32. Hasan F, Jeffers L, De Medina M et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 589-91.
33. Simonetti RG, Camma C, Fiorello F et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann. Intern. Med. 1992; 116: 97-102.
34. Katkov WN, Dienstag JL, Cody H et al. Role of hepatitis C virus in non-B chronic liver disease. Arch. Intern. Med. 1991; 151: 1548-52.
35. Furuta T, Kanematsu T, Matsumata T et al. Clinicopathologic features of hepatocellular carcinoma in young patients. Cancer 1990; 66: 2395-8.